Previous Page  9 / 36 Next Page
Information
Show Menu
Previous Page 9 / 36 Next Page
Page Background

Page 63

Notes:

conferenceseries

.com

Volume 7, Issue 2 (Suppl)

J Biotechnol Biomater

ISSN: 2155-952X JBTBM, an open access journal

Biomaterials 2017

March 27-28, 2017

2

nd

Annual Conference and Expo on

March 27-28, 2017 Madrid, Spain

Eloisa Gonzalez-Lavado et al., J Biotechnol Biomater 2017, 7:2 (Suppl)

http://dx.doi.org/10.4172/2155-952X.C1.074

Multi-walled carbon nanotubes (MWCNTs) as cytotoxic drug delivery systems in the treatment of cancer

Eloisa Gonzalez-Lavado

1

, Esperanza Padin-Gonzalez

1

, Nerea Iturrioz

1

, Tomas Torroba

2

and

Monica L Fanarraga

1

1

University of Cantabria, Spain

2

Universidad de Burgos, Spain

O

ur laboratory has focused on the intrinsic anti-proliferative, anti- migratory and cytotoxic effects of carbon nanotubes (CNTs).

We have shown how MWCNTs interact with microtubules assembling biosynthetic polymers triggering serious biomechanical

cellular defects that lead to cancer cell death. These properties of CNTs produce antitumoral effects in solid melanoma tumors

in

vivo

. The huge surface area of CNTs maximizes their ability to interact with many biological components and different chemicals,

constituting their biocorona. Taking into account these surface properties, we aimed to increase these intrinsic antitumoral effects

of CNTs functionalizing these nanomaterials with a well-known anti-tumoral drug (5-fluoracil)

in vitro

in melanoma cells and

in

vivo

in solid malignant melanomas produced by allograft transplantation in murine recipients. We have double-coated CNTs with

an internal chemical layer surrounded by a second coat of proteins. The first layer carrying chemicals, either a dye (as a proof-of-

concept) or a drug (5-fluoracil) and the second being a serum protein coating layer, both assembling the biocorona. The protein

coating serves for (1) CNTs recognition by cellular receptors, (2) endocytosis, (3) protection of the chemical component attached to

the nanotube surface until protein degradation that takes place at the lysosome, and (4) the release of the transported drug during

the first 5-9 hours next to the internalization process. CNTs loaded with 5-fluoracil double coated with serum proteins display a

significantly enhanced antitumoral effect

in vitro

and

in vivo

in mice bearing solid melanoma tumors.

Biography

Eloisa Gonzalez-Lavado is a PhD student in the Nanomedicine Group of the University of Cantabria (Spain). I did a chemistry Bachelor’s degree at the University of

Extremadura (Spain).I have an european interuniversity master’s degree in theoretical chemistry and computational modelling. Currently I am working with carbon

nanotubes and their biomedical aplications, especially in Cancer, studying their biocompatibility, their capability as nanocarriers and their own antitumoral effect.

eloisa.gonzalez@alumnos.unican.es